ArticleHaematologica2026

Phase I study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with sickle cell anemia.

Bart J Biemond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.